HLHIX: AllianzGI Health Sciences Institutional

Welcome to MutualFunds.com

Please help us personalize your experience and select the one that best describes you.

Your personalized experience is almost ready.

Join other Individual Investors receiving FREE personalized market updates and research. Join other Institutional Investors receiving FREE personalized market updates and research. Join other Financial Advisors receiving FREE personalized market updates and research.

Thank you!

Check your email and confirm your subscription to complete your personalized experience.

Thank you for your submission

We hope you enjoy your experience

Channels

Find the latest content and information here about the 2019 Charles Schwab Impact Conference.

Advisors

Receive email updates about fund flows, news, upcoming CE accredited webcasts from industry thought leaders and more.

Content focused on helping financial advisors build successful client relationships and grow their business.

Content geared towards helping financial advisors build better client portfolios.

Get insights on the industry trends and investment news from leading fund managers and experts.

HLHIX AllianzGI Health Sciences Institutional


Profile

HLHIX - Profile

Vitals

  • YTD Return 2.5%
  • 3 Yr Annualized Return 6.4%
  • 5 Yr Annualized Return 0.4%
  • Net Assets $160 M
  • Holdings in Top 10 44.2%

52 WEEK LOW AND HIGH

$35.18
$29.58
$36.23

Expenses

OPERATING RELATED FEES

  • Expense Ratio 1.12%

SALES FEES

  • Front Load N/A
  • Deferred Load N/A

BROKERAGE FEES

  • Turnover 102.00%

TRADING FEES

  • Max Redemption Fee N/A

Min Investment

  • Standard (Taxable) $1,000,000
  • IRA N/A

Fund Classification


Distributions

  • YTD Total Return 2.5%
  • 3 Yr Annualized Total Return 11.9%
  • 5 Yr Annualized Total Return 8.0%
  • Capital Gain Distribution Frequency Annually
  • Net Income Ratio 0.39%
DIVIDENDS
  • Dividend Yield 0.0%
  • Dividend Distribution Frequency Annually

Fund Details

  • Legal Name
    AllianzGI Health Sciences Fund
  • Fund Family Name
    Allianz Funds
  • Inception Date
    Dec 22, 2014
  • Shares Outstanding
    N/A
  • Share Class
    Inst
  • Currency
    USD
  • Domiciled Country
    United States
  • Manager
    Peter Pirsch

Fund Description

The fund seeks to achieve its objective by normally investing at least 80% of its net assets (plus borrowings made for investment purposes) in health sciences-related companies. The portfolio manager considers health sciences-related companies to include companies that design, manufacture or sell products or services used for or in connection with healthcare, medicine or life sciences. The fund will invest primarily in common stocks and other equity securities.


Sign up for Advisor Access

Receive email updates about best performers, news, CE accredited webcasts and more.


Categories

Performance

HLHIX - Performance

Return Ranking - Trailing

Period HLHIX Return Category Return Low Category Return High Rank in Category (%)
YTD 2.5% -2.5% 6.2% 60.63%
1 Yr 10.7% -0.9% 27.1% 44.44%
3 Yr 6.4%* -10.5% 22.8% 52.29%
5 Yr 0.4%* -10.1% 13.0% 44.23%
10 Yr N/A* -2.5% 15.2% 20.22%

* Annualized

Return Ranking - Calendar

Period HLHIX Return Category Return Low Category Return High Rank in Category (%)
2019 18.8% 5.7% 55.4% 62.39%
2018 -10.1% -25.3% 21.5% 71.17%
2017 17.7% -10.8% 43.9% 44.04%
2016 -7.7% -31.6% 6.9% 11.32%
2015 -9.3% -20.4% 13.8% 85.44%

Total Return Ranking - Trailing

Period HLHIX Return Category Return Low Category Return High Rank in Category (%)
YTD 2.5% -2.5% 6.2% 60.63%
1 Yr 10.7% -0.9% 27.1% 44.44%
3 Yr 11.9%* -10.5% 26.0% 21.10%
5 Yr 8.0%* -10.1% 16.1% 16.35%
10 Yr N/A* -2.5% 18.0% 42.70%

* Annualized

Total Return Ranking - Calendar

Period HLHIX Return Category Return Low Category Return High Rank in Category (%)
2019 18.8% 5.7% 55.4% 62.39%
2018 4.7% -25.3% 22.2% 3.60%
2017 17.7% -10.8% 45.8% 58.72%
2016 -7.7% -26.4% 8.7% 16.04%
2015 12.2% -16.6% 15.2% 13.59%

NAV & Total Return History


Holdings

HLHIX - Holdings

Concentration Analysis

HLHIX Category Low Category High HLHIX % Rank
Net Assets 160 M 3.51 M 46.9 B 77.95%
Number of Holdings 72 26 399 70.87%
Net Assets in Top 10 72.4 M 1.14 M 19.7 B 77.17%
Weighting of Top 10 44.24% 21.3% 75.6% 33.07%

Top 10 Holdings

  1. Novartis AG ADR 5.67%
  2. Merck & Co Inc 5.59%
  3. Bristol-Myers Squibb Company 5.33%
  4. Johnson & Johnson 5.21%
  5. AstraZeneca PLC ADR 4.89%
  6. UnitedHealth Group Inc 4.76%
  7. Sanofi SA ADR 4.37%
  8. Amgen Inc 3.03%
  9. Anthem Inc 2.81%
  10. AbbVie Inc 2.56%

Asset Allocation

Weighting Return Low Return High HLHIX % Rank
Stocks
96.84% 93.77% 103.54% 83.46%
Cash
3.16% 0.00% 5.82% 10.24%
Preferred Stocks
0.00% 0.00% 0.91% 24.41%
Other
0.00% -27.41% 5.17% 43.31%
Convertible Bonds
0.00% 0.00% 1.54% 12.60%
Bonds
0.00% 0.00% 20.60% 16.54%

Stock Sector Breakdown

Weighting Return Low Return High HLHIX % Rank
Healthcare
100.00% 58.44% 100.00% 7.87%
Utilities
0.00% 0.00% 0.00% 11.02%
Technology
0.00% 0.00% 15.59% 24.41%
Real Estate
0.00% 0.00% 5.84% 19.69%
Industrials
0.00% 0.00% 1.93% 16.54%
Financial Services
0.00% 0.00% 5.89% 32.28%
Energy
0.00% 0.00% 0.44% 15.75%
Communication Services
0.00% 0.00% 5.79% 15.75%
Consumer Defense
0.00% 0.00% 36.20% 15.75%
Consumer Cyclical
0.00% 0.00% 5.00% 17.32%
Basic Materials
0.00% 0.00% 2.02% 32.28%

Stock Geographic Breakdown

Weighting Return Low Return High HLHIX % Rank
US
76.58% 59.38% 100.00% 81.89%
Non US
20.26% 0.00% 39.25% 25.20%

Expenses

HLHIX - Expenses

Operational Fees

HLHIX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Expense Ratio 1.12% 0.10% 4.94% 55.93%
Management Fee 1.10% 0.09% 1.30% 91.34%
12b-1 Fee N/A 0.00% 1.00% N/A
Administrative Fee 0.30% 0.03% 0.40% 96.08%

Sales Fees

HLHIX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Front Load N/A 2.50% 5.75% N/A
Deferred Load N/A 1.00% 5.00% N/A

Trading Fees

HLHIX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Max Redemption Fee N/A 1.00% 2.00% N/A

Related Fees

Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.

HLHIX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Turnover 102.00% 0.00% 341.00% 92.74%

Distributions

HLHIX - Distributions

Dividend Yield Analysis

HLHIX Category Low Category High HLHIX % Rank
Dividend Yield 0.00% 0.00% 5.18% 21.26%

Dividend Distribution Analysis

HLHIX Category Low Category High Category Mod
Dividend Distribution Frequency Annually Annually Semi-Annually Annually

Net Income Ratio Analysis

HLHIX Category Low Category High HLHIX % Rank
Net Income Ratio 0.39% -2.24% 2.12% 18.90%

Capital Gain Distribution Analysis

HLHIX Category Low Category High Capital Mode
Capital Gain Distribution Frequency Annually Annually Semi-Annually Annually

Dividend Payout History

View More +

Fund Manager Analysis

HLHIX - Fund Manager Analysis

Managers

Peter Pirsch


Start Date

Tenure

Tenure Rank

Mar 22, 2018

1.86

1.9%

Mr. Pirsch is a senior portfolio manager, a senior analyst and a director with Allianz Global Investors, which he joined in 2018. He has management and research responsibilities for the Health Care team. Mr. Pirsch has 18 years of investment-industry experience. He previously worked at Aptigon Capital, Visium Asset Management, Surveyor Capital, Fred Alger Management and C.R. Bard. Before that, Mr. Pirsch was an associate director at UBS Investment Bank and an analyst at Wells Fargo. He has a B.A. in economics and international relations from Bucknell University, and an M.B.A. with a certificate in health sector management from Duke University, Fuqua School of Business. Mr. Pirsch is a CFA charterholder.

Tenure Analysis

Category Low Category High Category Average Category Mode
0.01 22.39 9.98 19.76